Detalhe da pesquisa
1.
Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial.
JAMA
; 330(2): 141-151, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37326473
2.
High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial.
Contemp Clin Trials
; 133: 107319, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625587
3.
Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design.
Contemp Clin Trials
; 104: 106346, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33684595